Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in Eur Respir J Retrieve available abstracts of 16 articles: HTML format

Single Articles

May 2025
1. SELMAN M, Buendia-Roldan I, Pardo A
   Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis.
   Eur Respir J. 2025;65:2402418.
   PubMed     Abstract available
   
   
   March 2025
2. RATSIHORIMANANA R, Maitre T, Dusselier M, Triet Ngo M, et al
   Recurrent respiratory papillomatosis in adults with lower respiratory tract involvement: a retrospective study of the OrphaLung and GETIF networks.
   Eur Respir J. 2025;65:2400618.
   PubMed     Abstract available
   
   
   December 2024
3. WENG C, Zhao Y, Song M, Shao Z, et al
   Mosaic loss of chromosome Y, tobacco smoking and risk of age-related lung diseases: insights from two prospective cohorts.
   Eur Respir J. 2024;64:2400968.
   PubMed     Abstract available
   
   
   November 2024
4. YOON HY, Kim H, Bae Y, Song JW, et al
   Pirfenidone and risk of lung cancer development in IPF: a nationwide population-based study.
   Eur Respir J. 2024 Nov 7:2401484. doi: 10.1183/13993003.01484-2024.
   PubMed     Abstract available
   
   
   June 2024
5. D'AMOURS MF, Wu FTH, Theisen-Lauk O, Chan EK, et al
   Surgically Resectable Non-Small Cell Lung Cancer: A Contemporary Approach.
   Eur Respir J. 2024 Jun 6:2400332. doi: 10.1183/13993003.00332-2024.
   PubMed     Abstract available
   
   
   
6. SEIJO LM, Zulueta JJ
   The tip of the iceberg: a plethora of lung nodules in the general population.
   Eur Respir J. 2024;63:2400889.
   PubMed    
   
   
   
7. CAI J, Vonder M, Du Y, Pelgrim GJ, et al
   Who is at risk of lung nodules on low-dose CT in a Western country? A population-based approach.
   Eur Respir J. 2024;63:2301736.
   PubMed     Abstract available
   
   
   
8. PORCEL JM
   Pleural mesothelioma: surgery questioned again?
   Eur Respir J. 2024;63:2400896.
   PubMed    
   
   
   
9. RASKIN J, Surmont V, Maat APWM, Yahia M, et al
   A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205.
   Eur Respir J. 2024;63:2302114.
   PubMed     Abstract available
   
   
   May 2024
10. SESE L, Annesi-Maesano I
    Lung cancer and idiopathic pulmonary fibrosis: environmental exposures are the key.
    Eur Respir J. 2024;63:2400760.
    PubMed    
    
    
    April 2024
11. BRUDON A, Legendre M, Mageau A, Bermudez J, et al
    High risk of lung cancer in surfactant-related gene variant carriers.
    Eur Respir J. 2024 Apr 4:2301809. doi: 10.1183/13993003.01809-2023.
    PubMed     Abstract available
    
    
    
12. LEWIS KE
    Smoking cessation at lung cancer screening: joining (life-saving) dots.
    Eur Respir J. 2024;63:2400550.
    PubMed    
    
    
    March 2024
13. YOON HY, Kim SY, Song JW
    Association Between High Levels of Nitrogen Dioxide and Increased Cumulative Incidence of Lung Cancer in Patients with Idiopathic Pulmonary Fibrosis.
    Eur Respir J. 2024 Mar 7:2301181. doi: 10.1183/13993003.01181-2023.
    PubMed     Abstract available
    
    
    February 2024
14. 
    "ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer." E.L. O'Dowd, I. Tietzova, E. Bartlett, et al. Eur Respir J 2023; 62: 2300533.
    Eur Respir J. 2024;63:2350533.
    PubMed    
    
    
    January 2024
15. OBACZ J, Valer JA, Nibhani R, Adams TS, et al
    Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma.
    Eur Respir J. 2024;63:2300143.
    PubMed     Abstract available
    
    
    October 2023
16. O'DOWD EL, Tietzova I, Bartlett E, Devaraj A, et al
    ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
    Eur Respir J. 2023 Oct 6:2300533. doi: 10.1183/13993003.00533-2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.